GNCA - Genocea Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $30.91. This is a potential upside of $30.91 (0%) from yesterday's end of day stock price of $0.

Genocea Biosciences's activity chart (see below) currently has 32 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 32.1 days.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 28-Apr-2022. First documented stock forecast 04-Mar-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

3 years 5 months 24 days ago
(28-Apr-2022)

0/2 (0%)

$10 (100.00%)

Hold

$0.16

$0.16 (0.00%)

$18

3 years 5 months 24 days ago
(28-Apr-2022)

1/3 (33.33%)

$-0.12 (-42.86%)

25

Hold

$9

3 years 5 months 24 days ago
(28-Apr-2022)

1/2 (50%)

$5.4 (150.00%)

4

Buy

4 years 8 months 12 days ago
(10-Feb-2021)

0/1 (0%)

$9.91 (162.73%)

Buy

$8

$8 (0.00%)

$15

5 years 2 months 23 days ago
(29-Jul-2020)

0/2 (0%)

$4.55 (131.88%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GNCA (Genocea Biosciences) average time for price targets to be met?

On average it took 32.1 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on GNCA (Genocea Biosciences) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on GNCA

Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?

Christopher James with highest potential upside - $136

Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?

Chad Messer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?